Thinking up tomorrow's medicine
News
[press release] ALGENICS receives grant to support development of its technology for the production of monoclonal antibodies in oncology
Algenics, the biopharmaceutical company offering a unique microalgae-based solution for the development of recombinant biotherapeutics, announced that it has received a grant from OSEO, the French innovation agency, with the support of the European Regional Development Fund.
The portrait of an innovative stakeholder from the Pays de la Loire region
As an engineer by training, Pascal Mounier's career has composed two different periods. After learning about project management, he founded CERIS in 1999. CERIS now has 120 staff and provides services to pharmaceutical and chemical companies.
ArronaxPlus confirms the city of Nantes' leadership in the field of nuclear medicine
The ArronaxPlus project has been selected for funding under the second round of the Equipex infrastructure call for proposals (part of the French government's "Investing for the Future" program). The €8 million project notably aims at developing four hi-tech platforms for translational research in nuclear medicine.
QUANTICARDI: a federative heart imaging project based in Nantes
The Quanticardi project consists in developing the use of positron emission tomography (PET) imaging in the field of cardiology in Europe. The project has been funded by the French government and accredited by Atlanpole Biotherapies as part of the cluster’s radiopharmaceuticals theme. Quanticardi is led by the company Lemer Pax, with Keosys, Arronax and the University of Nantes’ Subatech, IRCCyN and CRCNA groups as project partners. The project has considerable medical and economic potential.
Events
19 - 21 mars 2012 : BioEurope Spring Amsterdam
An Atlanpole Biotherapies delegation will attend BioEurope Spring in Amsterdam. Meet us and our booth #75 with some companies from the cluster: Algenics, Clean Cells, Biomedical Tissue, Cytune Pharma, Keosys, Myelomax, Novasep and Porsolt. Actually, the business convention will be completed by a 2-days Ubifrance trade mission to Belgium and the Netherlands. This proposition promoted by Atlanpole Biotherapies for its members is really another opportunity to develop business.
"Stem cells applied to cell transplantation and reconstructive medicine", Nantes
The CENTAURE Foundation (a thematic research and healthcare network dedicated to the transplantation sciences) is delighted to invite you to attend its 7th scientific meeting entitled "Stem cells applied to cell transplantation and reconstructive medicine ".
The 10th edition of the "Clinical Dialogue in Transplantation" meeting
The 10th edition of the "Clinical Dialogue in Transplantation" meeting (organized by Novartis Pharma) will focus on the theme: "Long- term immunological events".
"Discovery Mission" to the Netherlands
As a follow-on from the BioEurope Spring show in Amsterdam and in order to make the most of the trip for the cluster's companies, Atlanpole Biotherapies has enabled its members to attend an additional trade mission to Belgium and The Netherlands (organized by Ubifrance).
Atlanpole Biotherapies gives you access to extended skills, from biodiagnostic to biomedicine.
For pharmaceutical and biotech companies or research laboratories looking for high level partners devoted to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient, within 4 areas of excellence: immunobiotherapies, radiopharmaceuticals, biomaterials and cell & gene therapies.
